DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis

FRA:AJ91 • DE000A1A6WE6

13.4 EUR
-0.1 (-0.74%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to AJ91. AJ91 was compared to 11 industry peers in the Health Care Technology industry. AJ91 scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AJ91 has a decent growth rate and is not valued too expensively. AJ91 also has an excellent dividend rating. This makes AJ91 very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year AJ91 was profitable.
  • In the past year AJ91 had a positive cash flow from operations.
  • AJ91 had positive earnings in each of the past 5 years.
  • In the past 5 years AJ91 always reported a positive cash flow from operatings.
AJ91.DE Yearly Net Income VS EBIT VS OCF VS FCFAJ91.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • AJ91 has a better Return On Assets (9.09%) than 81.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.18%, AJ91 belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.86%, AJ91 is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AJ91 is in line with the industry average of 8.41%.
Industry RankSector Rank
ROA 9.09%
ROE 13.18%
ROIC 8.86%
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
AJ91.DE Yearly ROA, ROE, ROICAJ91.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • AJ91 has a better Profit Margin (9.82%) than 72.73% of its industry peers.
  • In the last couple of years the Profit Margin of AJ91 has remained more or less at the same level.
  • AJ91 has a better Operating Margin (12.33%) than 72.73% of its industry peers.
  • AJ91's Operating Margin has declined in the last couple of years.
  • AJ91 has a better Gross Margin (79.18%) than 72.73% of its industry peers.
  • In the last couple of years the Gross Margin of AJ91 has remained more or less at the same level.
Industry RankSector Rank
OM 12.33%
PM (TTM) 9.82%
GM 79.18%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
AJ91.DE Yearly Profit, Operating, Gross MarginsAJ91.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AJ91 is creating some value.
  • Compared to 1 year ago, AJ91 has about the same amount of shares outstanding.
  • AJ91 has more shares outstanding than it did 5 years ago.
  • AJ91 has a better debt/assets ratio than last year.
AJ91.DE Yearly Shares OutstandingAJ91.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
AJ91.DE Yearly Total Debt VS Total AssetsAJ91.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • AJ91 has an Altman-Z score of 4.57. This indicates that AJ91 is financially healthy and has little risk of bankruptcy at the moment.
  • AJ91 has a better Altman-Z score (4.57) than 81.82% of its industry peers.
  • AJ91 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.57
ROIC/WACC1.24
WACC7.12%
AJ91.DE Yearly LT Debt VS Equity VS FCFAJ91.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 2.74 indicates that AJ91 has no problem at all paying its short term obligations.
  • AJ91 has a Current ratio of 2.74. This is amongst the best in the industry. AJ91 outperforms 81.82% of its industry peers.
  • A Quick Ratio of 2.50 indicates that AJ91 has no problem at all paying its short term obligations.
  • AJ91's Quick ratio of 2.50 is amongst the best of the industry. AJ91 outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.5
AJ91.DE Yearly Current Assets VS Current LiabilitesAJ91.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 133.18% over the past year.
  • AJ91 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.57% yearly.
  • AJ91 shows a small growth in Revenue. In the last year, the Revenue has grown by 0.69%.
  • The Revenue has been growing by 10.68% on average over the past years. This is quite good.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AJ91.DE Yearly Revenue VS EstimatesAJ91.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.88, AJ91 is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 90.91% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.97. AJ91 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.88
Fwd PE N/A
AJ91.DE Price Earnings VS Forward Price EarningsAJ91.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 90.91% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, AJ91 is valued cheaper than 81.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.44
EV/EBITDA 4.5
AJ91.DE Per share dataAJ91.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • AJ91 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.22
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.56%, AJ91 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.34, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
  • AJ91's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 5.56%

5.2 History

  • The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
AJ91.DE Yearly Dividends per shareAJ91.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
  • AJ91's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
AJ91.DE Yearly Income VS Free CF VS DividendAJ91.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M
AJ91.DE Dividend Payout.AJ91.DE Dividend Payout, showing the Payout Ratio.AJ91.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DOCCHECK AG

FRA:AJ91 (2/13/2026, 7:00:00 PM)

13.4

-0.1 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)09-20
Earnings (Next)N/A
Inst Owners7.92%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap67.94M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.56%
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.88
Fwd PE N/A
P/S 1.26
P/FCF 10.44
P/OCF 8.89
P/B 1.7
P/tB 1.7
EV/EBITDA 4.5
EPS(TTM)1.04
EY7.76%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY9.58%
OCF(TTM)1.51
OCFY11.25%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1.22
Graham Number13.6
Profitability
Industry RankSector Rank
ROA 9.09%
ROE 13.18%
ROCE 14.96%
ROIC 8.86%
ROICexc 17.58%
ROICexgc 17.72%
OM 12.33%
PM (TTM) 9.82%
GM 79.18%
FCFM 12.1%
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.88%
Cap/Sales 2.11%
Interest Coverage 250
Cash Conversion 83.94%
Profit Quality 123.15%
Current Ratio 2.74
Quick Ratio 2.5
Altman-Z 4.57
F-Score6
WACC7.12%
ROIC/WACC1.24
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%

DOCCHECK AG / AJ91.DE FAQ

Can you provide the ChartMill fundamental rating for DOCCHECK AG?

ChartMill assigns a fundamental rating of 7 / 10 to AJ91.DE.


What is the valuation status of DOCCHECK AG (AJ91.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DOCCHECK AG?

DOCCHECK AG (AJ91.DE) has a profitability rating of 7 / 10.


What is the financial health of DOCCHECK AG (AJ91.DE) stock?

The financial health rating of DOCCHECK AG (AJ91.DE) is 9 / 10.